Hiroki Hasegawa
Assistant Research Manager

Mitsubishi Gas Chemical

Is this your profile?

About

Hiroki Hasegawa is an Assistant Research Manager in Mitsubishi Gas Chemical’s Advanced Business Development division. He earned a Diploma in Science in 2013 and a Master of Science degree in 2015 from Osaka University (Japan).

He has worked for MGC since April 2015, in charge of macromolecular science, especially in composition development of thermosetting resin. In 2018, he joined the development team for OXYCAPT.

Contributions

PREFILLED SYRINGES

USING OXYCAPT™ MULTILAYER PLASTIC VIAL FOR GENE AND CELL THERAPIES STORED IN DRY ICE AND LIQUID NITROGEN

Hiroki Hasegawa and Tomohiro Suzuki consider the various challenges presented by cold-chain logistics to both traditional glass vials and many cyclo-olefin polymer alternatives, and how Mitsubishi Gas Chemical's OXYCAPT™ vials offer significant advantages for maintaining container closure integrity compared with other materials on the market.

More contributions

OXYCAPT VIAL’S CONTAINER CLOSURE INTEGRITY WITH DRY ICE AFTER FREEZING AND THAWING

Hiroki Hasegawa and Tomohiro Suzuki review the benefits of MGC’s multilayer plastic OXYCAPT™ vials and discuss a recent experiment comparing the ability of OXYCAPT and COP vials to resist permeation by CO₂ upon thawing after being stored below -60°C.

CONTAINER CLOSURE INTEGRITY OF OXYCAPT™ VIAL AT -80°C WITH DRY ICE

Hiroki Hasegawa and Tomohiro Suzuki highlight the overall benefits of OXYCAPT, Mitsubishi Gas Chemical’s multilayer plastic vial, as a primary container for biologics and gene and cell therapies and discuss the company’s recent investigation into OXYCAPT’s performance at -80°C under dry ice conditions.

PREFILLED SYRINGES

NEW EXTRACTABLES DATA FOR OXYCAPT™ MULTILAYER PLASTIC VIAL FOR BIOLOGICS & GENE/CELL THERAPY

Hiroki Hasegawa and Tomohiro Suzuki review the properties of OXYCAPT™, Mitsubishi Gas Chemical’s multilayer material for primary biologic packaging, and share the data from the latest study on OXYCAPT’s extractables profile.

PREFILLED SYRINGES

OXYCAPT™: A SUPERIOR PRIMARY CONTAINER MATERIAL FOR BIOLOGICS AND GENE AND CELL THERAPIES

Hiroki Hasegawa and Tomohiro Suzuki provide an overview of the OXYCAPT multilayer vial and syringe, along with a discussion of how OXYCAPT fares at low and very low temperatures.

INDUSTRIALISATION

UPDATE ON OXYCAPT™ MULTILAYER PLASTIC VIAL AND SYRINGE

Hiroki Hasegawa and Tomohiro Suzuki discuss the advantages of OXYCAPT™ multilayer plastic vial and syringe, which combine the benefits of cyclo-olefin polymer with excellent oxygen and UV barrier properties. In particular, the authors focus on recent studies that highlight OXYCAPT’s very low levels of extractables.

ADVANCES IN MULTILAYER TECHNOLOGY FOR WEARABLE INJECTOR PRIMARY PACKAGING

Hiroki Hasegawa and Tomohiro Suzuki discuss how multilayer technology used in the drinks bottle industry can be used to create syringes and vials for biologics, avoiding problems such as oxidation and absorption that occur with other materials.

Top